products-page 
Tech Zulu Event
OCTOBER 11, 2013
Pitching stories and getting your name out to various companies and editors requires a lot of work. I have been on every end of the business in terms of journalism and publishing. For all those who want to talk about the fragmentation of media and the models for journalism is in trouble; it’s actually not.
Both Sides of the Table
NOVEMBER 13, 2012
When I did it was a little too close to home for a company to have me publish it. A while back I received a frantic phone call from the CEO of a company in which I invested. The company had their holding statement. The story ran in the print edition of a major news journal. Much time has passed. Their PR firm was ready.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Both Sides of the Table
NOVEMBER 29, 2009
I recently got a phone call from an entrepreneur whom I respect and who runs a company that I hope will do great things one day. He had pitched me in the past and I told him that for a variety of reasons his company was too early stage for me but that I would happily keep track of their progress. PR is subtle.
Both Sides of the Table
DECEMBER 25, 2015
Like many of you I read in awe last week about the accomplishments of the Washington Post since Jeff Bezos acquired the company two years ago. Either I believe in high-quality journalism or I don’t. I clicked on the customer service, contact us page, to talk with a rep. Then I hit the paywall. Fair enough.
InfoChachkie
JUNE 3, 2013
John Lusk, along with his Co-Author Kyle Harrison, leveraged their humble company''s newsletter into The MouseDriver Chronicles , a New York Times bestselling book. Upon graduation from Wharton, John and Kyle launched a startup based upon a simple, pedestrian product: a computer mouse shaped like the head of a golf driver.
socalTECH
AUGUST 2, 2017
We chatted with Alan about the company, the process of taking a new, genetic test to market, and his experience taking research from the University of Southern California and University of Utah and commercializing that research. Alan Horsager: We are an epigenetics data company. How did you decide to turn this into a company?
Xconomy
AUGUST 16, 2016
A recent Wall Street Journal article that raised the possibility of Biogen as the target of another huge pharma buyout cited the lack of productivity as a major driver of M&A in the pharmaceutical industry. The increasing need for new drugs is intense.
Expert insights. Personalized for you.
90 
Let's personalize your content